Ali Chehrei
Pars Medical Laboratory, Arak University of Medical Sciences, Arak, Iran
[ 1 ] - 5-Year Survival in Gastric Adenocarcinoma with Epithelial and Stromal Versican Expression
Background & Objective: Gastric cancer is the second most frequent cause of cancer death worldwide, despite differences in incidence around the world. The majority of gastric cancer cases concern gastric adenocarcinoma, which has a fairly high 5-year survival rate when coupled with early-stage diagnosis. Versican, a member of the aggregating chondroitin sulfate proteoglycans fa...
Co-Authors